Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Simultaneous Assessment of Clearance, Metabolism, Induction, and Drug-Drug Interaction Potential Using a Long-Term In Vitro Liver Model for a Novel Hepatitis B Virus Inhibitor.

Kratochwil NA, Triyatni M, Mueller MB, Klammers F, Leonard B, Turley D, Schmaler J, Ekiciler A, Molitor B, Walter I, Gonsard PA, Tournillac CA, Durrwell A, Marschmann M, Jones R, Ullah M, Boess F, Ottaviani G, Jin Y, Parrott NJ, Fowler S.

J Pharmacol Exp Ther. 2018 May;365(2):237-248. doi: 10.1124/jpet.117.245712. Epub 2018 Feb 16.

PMID:
29453199
2.

Model-based assessment of erlotinib effect in vitro measured by real-time cell analysis.

Benay S, Meille C, Kustermann S, Walter I, Walz A, Gonsard PA, Pietilae E, Kratochwil N, Iliadis A, Roth A, Lave T.

J Pharmacokinet Pharmacodyn. 2015 Jun;42(3):275-85. doi: 10.1007/s10928-015-9415-3. Epub 2015 Mar 31.

PMID:
25822652
3.

A comparative analysis of patch-leaving decision rules in a parasitoid family.

Wajnberg E, Gonsard PA, Tabone E, Curty C, Lezcano N, Colazza S.

J Anim Ecol. 2003 Jul;72(4):618-626. doi: 10.1046/j.1365-2656.2003.00731.x.

PMID:
30893956

Supplemental Content

Loading ...
Support Center